Key result
Among 400 patients undergoing valve replacement (77 with calcification), degenerative stenotic lesions, serum GGT (>90 IU/l), and total bilirubin (15-20 μmol/l) were risk factors for calcification.
Why the study?
What are the risk factors associated with left-sided cardiac valve calcification in patients undergoing valve replacement surgery?
Case-Control (n=400)
What are the risk factors associated with left-sided cardiac valve calcification in patients undergoing valve replacement surgery?
Answers are grounded in this paper and cite their sources.
Routine blood tests including GGT, TBIL, and calcium levels, along with lesion type, can help identify risk for cardiac valve calcification in patients undergoing valve replacement.
OBJECTIVES: To identify risk factors associated with cardiac valve calcification that is easily detectable through routine blood tests in patients who received valve replacement therapy. METHODS: Four hundred patients with valvular heart disease who underwent valve replacement surgery between December 2009 and January 2013 were enrolled in this study. Of these, 77 had valve calcification; the other 323 did not. Multivariate logistic regression analysis was used to assess for risk factors associated with valve calcification. RESULTS: In our study population, rheumatic valve lesions were the most common reason for valve replacement. Degenerative nonstenotic valve lesion was a protective factor and degenerative stenotic valve lesion was a strong risk factor for valve calcification. Serum levels of gamma-glutamyl transferase (GGT) of between 30 and 46 IU/l and >90 IU/l and total bilirubin (TBIL) of between 15 and 20 μmol/l were positively correlated with valve calcification. Meanwhile, serum calcium (Ca2+) levels of between 2.3 and 2.4 mmol/l were negatively correlated with rheumatic valve calcification. CONCLUSIONS: Degenerative stenotic lesion is a risk factor and degenerative nonstenotic lesion a protective factor for cardiac valve calcification. Serum GGT and TBIL levels are positively correlated and serum Ca2+ levels negatively correlated with rheumatic cardiac valve calcification.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2016) conducted a case-control in valvular heart disease (n=400). Degenerative valve lesions and serum biomarkers (GGT, TBIL, Ca2+) vs. Patients without valve calcification was evaluated on Cardiac valve calcification. Among 400 patients undergoing valve replacement (77 with calcification), degenerative stenotic lesions, serum GGT (>90 IU/l), and total bilirubin (15-20 μmol/l) were risk factors for calcification.
Synapse has enriched 10 related papers. Consider them for comparative context: